Skip to content
10-Q

Quarterly Report

ADAPTIMMUNE THERAPEUTICS PLC ADAPY

0001558370-25-011307

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 1.59B sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.58B sh
Shares Diluted Q2 2025 · Jun 30, 2025 1.56B sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.56B sh
Shares Diluted Q2 2025 · Jun 30, 2024 1.52B sh
Capex Q2 2025 · Jun 30, 2025 $1.28M
Capex Q2 2025 · Jun 30, 2024 $524K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$101.37M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $15.45M
Long Term Debt Q2 2025 · Jun 30, 2025 $25.68M
Long Term Debt Q2 2025 · Dec 31, 2024 $50.24M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $26.06M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $91.14M
Stockholders Equity Q2 2025 · Jun 30, 2025 −$70.96M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$37.43M
Stockholders Equity Q2 2025 · Dec 31, 2024 $11.85M
Stockholders Equity Q2 2025 · Jun 30, 2024 $96.27M
Stockholders Equity Q2 2025 · Mar 31, 2024 $24.38M
Stockholders Equity Q2 2025 · Dec 31, 2023 $39.51M
Current Liabilities Q2 2025 · Jun 30, 2025 $51.51M
Current Liabilities Q2 2025 · Dec 31, 2024 $64.53M
Total Liabilities Q2 2025 · Jun 30, 2025 $201.59M
Total Liabilities Q2 2025 · Dec 31, 2024 $234.11M
Current Assets Q2 2025 · Jun 30, 2025 $78.12M
Current Assets Q2 2025 · Dec 31, 2024 $188.17M
Total Assets Q2 2025 · Jun 30, 2025 $130.63M
Total Assets Q2 2025 · Dec 31, 2024 $245.96M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.02
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.05
Eps Diluted Q2 2025 · Jun 30, 2024 $0.04
Eps Diluted Q2 2025 · Jun 30, 2024 $0.01
Eps Basic Q2 2025 · Jun 30, 2025 −$0.02
Eps Basic Q2 2025 · Jun 30, 2025 −$0.05
Eps Basic Q2 2025 · Jun 30, 2024 $0.05
Eps Basic Q2 2025 · Jun 30, 2024 $0.01
Sga Expense Q2 2025 · Jun 30, 2025 $18.49M
Sga Expense Q2 2025 · Jun 30, 2025 $41.77M
Sga Expense Q2 2025 · Jun 30, 2024 $19.08M
Sga Expense Q2 2025 · Jun 30, 2024 $38.82M
Rd Expense Q2 2025 · Jun 30, 2025 $22.98M
Rd Expense Q2 2025 · Jun 30, 2025 $51.84M
Rd Expense Q2 2025 · Jun 30, 2024 $40.45M
Rd Expense Q2 2025 · Jun 30, 2024 $75.66M
Net Income Q2 2025 · Jun 30, 2025 −$30.34M
Net Income Q2 2025 · Jun 30, 2025 −$77.92M
Net Income Q2 2025 · Mar 31, 2025 −$47.58M
Net Income Q2 2025 · Jun 30, 2024 $69.52M
Net Income Q2 2025 · Jun 30, 2024 $21.02M
Net Income Q2 2025 · Mar 31, 2024 −$48.5M
Operating Income Q2 2025 · Jun 30, 2025 −$30.29M
Operating Income Q2 2025 · Jun 30, 2025 −$76.02M
Operating Income Q2 2025 · Jun 30, 2024 $68.7M
Operating Income Q2 2025 · Jun 30, 2024 $19.44M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $2.5M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.38M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $0
Revenue Q2 2025 · Jun 30, 2025 $13.68M
Revenue Q2 2025 · Jun 30, 2025 $20.96M
Revenue Q2 2025 · Jun 30, 2024 $128.23M
Revenue Q2 2025 · Jun 30, 2024 $133.91M